Thursday, November 21, 2024

Canada’s Politics and Government News Source Since 1989

Thursday, November 21, 2024 | Latest Paper

In strengthening Canada’s health care, we must maintain employer-sponsored drug plans

Displacing comprehensive employer-sponsored drug plans with a single-payer universal pharmacare model would have adverse consequences, including reduced coverage, lost tax revenue, slower access to new drugs, and higher costs for employers, unions, and families.

Opinion
BY CAROLYNE EAGAN
February 21, 2024

Opinion | BY CAROLYNE EAGAN | February 21, 2024

More Opinion

As COP29 wraps up, will Canada finally stop funding fossils this fall?

OpinionBY JULIA LEVIN

Addressing the threat of antimicrobial resistance

OpinionBY INDEPENDENT SENATOR MOHAMED-IQBAL RAVALIA

The wisdom of Homer Simpson and Aaron Sorkin

OpinionBY JAMIE CARROLL

Climate finance should target resilient food systems

OpinionBY CAROL THIESSEN

Trump’s ‘America First’ plans may undermine global trade

OpinionBY ANDREW CADDELL

Related Stories

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

OpinionBY KRISTINA ACRI

Time for Canada to step up on drug coverage, says Toronto doctor

Single-payer pharmacare plan remains the best option, says Toronto reader

Universal pharmacare plan needs to improve access without disrupting care

OpinionBY SANDRA HANNA